• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期给予μ-阿片受体拮抗剂甲氧辛胺可降低小鼠的享乐反应,而不影响其动机。

Chronic administration of methocinnamox, a mu-opioid receptor antagonist, reduces hedonic response without impacting motivation in mice.

作者信息

Sheikh Misbah, Cambre Emily, Langreck Cory, Javitch Jonathan A, Canetta Sarah E

机构信息

Department of Neuroscience, Barnard College, New York, NY, USA.

Division of Developmental Neuroscience, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA.

出版信息

Psychopharmacology (Berl). 2025 May 10. doi: 10.1007/s00213-025-06801-2.

DOI:10.1007/s00213-025-06801-2
PMID:40346429
Abstract

RATIONALE

Genetic and pharmacological studies suggest that signaling through the mu opioid receptor (MOR) is essential for motivation to seek, and hedonic response to, both drugs of abuse as well as natural rewards. Given that impairments in hedonic reactivity and motivation are key behavioral features of depression, we wondered whether sustained deficits in endogenous opioid signaling in adulthood could produce these 'depression-related' behavioral phenotypes.

OBJECTIVES

To investigate the effect of chronic MOR blockade in adulthood on motivation and hedonic response to a food reward, as well as whether these behavioral variables are correlated at the individual animal level.

METHODS

We chronically administered the pseudo-irreversible MOR antagonist methocinnamox (MCAM) for three weeks prior to assessing motivation and hedonic reactivity for a food reward in the progressive ratio and lickometer tasks, respectively. We then assessed whether motivation and hedonic response to reward were correlated at the individual animal level.

RESULTS

Chronic administration of MCAM decreased hedonic response, while leaving goal-directed motivation intact. In addition, there was a weak negative correlation between motivation and hedonic response in individual mice treated with chronic MCAM, but not control mice.

CONCLUSIONS

Chronic blockade of the MOR decreases hedonic response, without impacting motivation to work for the same reward. Although the different components of reward processing such as motivation and hedonic response may be related, they appear to be dissociable.

摘要

原理

基因和药理学研究表明,通过μ阿片受体(MOR)的信号传导对于寻求药物和滥用药物以及自然奖励的动机和享乐反应至关重要。鉴于享乐反应性和动机受损是抑郁症的关键行为特征,我们想知道成年期内源性阿片信号的持续缺陷是否会产生这些“与抑郁症相关”的行为表型。

目的

研究成年期慢性MOR阻断对食物奖励的动机和享乐反应的影响,以及这些行为变量在个体动物水平上是否相关。

方法

在分别通过累进比率和舔舐计任务评估对食物奖励的动机和享乐反应性之前,我们长期给予伪不可逆MOR拮抗剂甲氧辛胺(MCAM)三周。然后,我们评估了在个体动物水平上对奖励的动机和享乐反应是否相关。

结果

长期给予MCAM会降低享乐反应,而目标导向的动机保持不变。此外,在长期接受MCAM治疗的个体小鼠中,动机与享乐反应之间存在微弱的负相关,但在对照小鼠中则不存在。

结论

MOR的慢性阻断会降低享乐反应,而不会影响为获得相同奖励而工作的动机。虽然奖励处理的不同组成部分,如动机和享乐反应可能相关,但它们似乎是可分离的。

相似文献

1
Chronic administration of methocinnamox, a mu-opioid receptor antagonist, reduces hedonic response without impacting motivation in mice.长期给予μ-阿片受体拮抗剂甲氧辛胺可降低小鼠的享乐反应,而不影响其动机。
Psychopharmacology (Berl). 2025 May 10. doi: 10.1007/s00213-025-06801-2.
2
Comparison of the -Opioid Receptor Antagonists Methocinnamox and Naloxone to Reverse and Prevent the Ventilatory Depressant Effects of Fentanyl, Carfentanil, 3-Methylfentanyl, and Heroin in Male Rats.比较阿片受体拮抗剂甲氧辛胺和纳洛酮对雄性大鼠芬太尼、卡芬太尼、3-甲基芬太尼和海洛因呼吸抑制作用的逆转和预防效果。
J Pharmacol Exp Ther. 2024 Sep 18;391(1):4-17. doi: 10.1124/jpet.123.002032.
3
TouchScreen-based phenotyping: altered stimulus/reward association and lower perseveration to gain a reward in mu opioid receptor knockout mice.基于触摸屏的表型分析:在μ阿片受体敲除小鼠中,改变了刺激/奖励关联,并且为了获得奖励而持续的时间更短。
Sci Rep. 2019 Mar 11;9(1):4044. doi: 10.1038/s41598-019-40622-6.
4
Decreased motivation to eat in mu-opioid receptor-deficient mice.μ-阿片受体缺陷小鼠进食动机降低。
Eur J Neurosci. 2007 Jun;25(11):3398-405. doi: 10.1111/j.1460-9568.2007.05595.x.
5
Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.美沙酮肉桂醇(MCAM)拮抗吗啡的行为抑制作用,而不损害恒河猴延迟匹配样本的准确性。
Psychopharmacology (Berl). 2020 Oct;237(10):3057-3065. doi: 10.1007/s00213-020-05592-y. Epub 2020 Aug 9.
6
Nociceptin/orphanin FQ, hedonic state and the response to abused drugs.孤啡肽、享乐状态与对成瘾药物的反应
Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Oct;24(5):295-8.
7
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of -Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats.美沙酮酮产生 - 阿片受体激动剂行为效应的持久拮抗作用,但不会延长大鼠的戒断症状。
J Pharmacol Exp Ther. 2019 Nov;371(2):507-516. doi: 10.1124/jpet.119.260331. Epub 2019 Aug 22.
8
Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.每日美沙酮治疗对恒河猴芬太尼自我给药的影响。
J Pharmacol Exp Ther. 2022 Aug;382(2):181-187. doi: 10.1124/jpet.122.001233. Epub 2022 May 28.
9
Mechanisms Underlying Motivational Deficits in Psychopathology: Similarities and Differences in Depression and Schizophrenia.精神病理学中动机缺陷的潜在机制:抑郁症和精神分裂症的异同
Curr Top Behav Neurosci. 2016;27:411-49. doi: 10.1007/7854_2015_376.
10
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys.μ阿片受体拮抗剂甲氧辛胺急性和反复给药对恒河猴芬太尼自我给药的影响。
Neuropsychopharmacology. 2020 Nov;45(12):1986-1993. doi: 10.1038/s41386-020-0698-8. Epub 2020 May 6.

本文引用的文献

1
A novel method for automatic pharmacological evaluation of sucrose preference change in depression mice.一种用于自动评估抑郁症小鼠蔗糖偏好变化的药理学新方法。
Pharmacol Res. 2021 Jun;168:105601. doi: 10.1016/j.phrs.2021.105601. Epub 2021 Apr 8.
2
TouchScreen-based phenotyping: altered stimulus/reward association and lower perseveration to gain a reward in mu opioid receptor knockout mice.基于触摸屏的表型分析:在μ阿片受体敲除小鼠中,改变了刺激/奖励关联,并且为了获得奖励而持续的时间更短。
Sci Rep. 2019 Mar 11;9(1):4044. doi: 10.1038/s41598-019-40622-6.
3
Potential roles for opioid receptors in motivation and major depressive disorder.
阿片受体在动机和重度抑郁症中的潜在作用。
Prog Brain Res. 2018;239:89-119. doi: 10.1016/bs.pbr.2018.07.009. Epub 2018 Sep 19.
4
Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking.μ、δ和κ 阿片受体在环境线索诱导的氧可酮觅药行为中的作用。
Eur J Neurosci. 2019 Aug;50(3):2075-2085. doi: 10.1111/ejn.13955. Epub 2018 Aug 1.
5
The effects of early life stress on reward processing.早期生活压力对奖励处理的影响。
J Psychiatr Res. 2018 Jun;101:80-103. doi: 10.1016/j.jpsychires.2018.02.002. Epub 2018 Feb 13.
6
Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking.前脑 GABA 能神经元中的 μ 阿片受体促进酒精奖赏和饮酒。
Addict Biol. 2019 Jan;24(1):28-39. doi: 10.1111/adb.12576. Epub 2017 Nov 2.
7
Decreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action.降低纹状体苍白球通路功能可通过激发目标导向行动的启动来增强动机。
J Neurosci. 2016 Jun 1;36(22):5988-6001. doi: 10.1523/JNEUROSCI.0444-16.2016.
8
Assessing anhedonia in depression: Potentials and pitfalls.评估抑郁症中的快感缺失:潜力与陷阱。
Neurosci Biobehav Rev. 2016 Jun;65:21-35. doi: 10.1016/j.neubiorev.2016.03.004. Epub 2016 Mar 6.
9
Dysfunctional Reward Processing in Depression.抑郁症中功能失调的奖赏处理
Curr Opin Psychol. 2015 Aug 1;4:114-118. doi: 10.1016/j.copsyc.2014.12.011.
10
Pleasure systems in the brain.大脑中的奖赏系统。
Neuron. 2015 May 6;86(3):646-64. doi: 10.1016/j.neuron.2015.02.018.